Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zhengzhou
Clinical trial register · China

Clinical Trials in Zhengzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Zhengzhou 38 Jiaozuo 4 Anyang 3 Kaifeng 3 Luoyang 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Henan Cancer Hospital75 The First Affiliated Hospital of Zhengzhou University38 Merck Sharp & Dohme LLC28 AbbVie21 Novartis Pharmaceuticals20 Clear sponsor filter
Site location
Zhengzhou38 Jiaozuo4 Anyang3 Kaifeng3 Luoyang3
All 29 locations
Target enrolment
to

Trials with a site in Zhengzhou

38 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
The First Affiliated Hospital of Zhengzhou University
Observational
100
Zhengzhou
2027-01-21
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 2
34
Zhengzhou
2026-11
Not yet open
The First Affiliated Hospital of Zhengzhou University
Observational
500
Guangzhou, Zhengzhou, Shanghai, Chengdu, Tianjin, Kunming
2026-09
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 2
88
Zhengzhou
2026-08-31
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 3
586
Zhengzhou
2026-06-01
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 3
564
Zhengzhou
2026-05-01
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 3
578
Zhengzhou
2026-04
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 1/2
50
Zhengzhou
2026-03
Not yet open
The First Affiliated Hospital of Zhengzhou University
Not applicable
204
Zhengzhou
2026-01-01
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 2
30
Zhengzhou
2025-12-30
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
50
Zhengzhou
2025-06-30
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
78
Zhengzhou
2025-06-15
Recruiting
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
NCT06896422Non-Small Cell Lung Cancer, Chemotherapy, PD1 Antibody, Glutathione
DrugGlutathione
The First Affiliated Hospital of Zhengzhou University
Phase 1
80
Zhengzhou
2025-06-01
Active, closed
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
NCT07203495Lung Diseases, Endocrine Diseases, Gastrointestinal Diseases
The First Affiliated Hospital of Zhengzhou University
Observational
200
Zhengzhou
2025-06-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
276
Zhengzhou
2025-03-17
Recruiting
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
NCT07104149Female, Age ≥ 18 Years Old, No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy, ECOG Score of 0-1, Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion
DrugsCadonilimab·Cisplatin
The First Affiliated Hospital of Zhengzhou University
Phase 2
29
Zhengzhou
2025-03-10
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
170
Zhengzhou
2025-03-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
170
Zhengzhou
2025-03-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
276
Zhengzhou
2025-03-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 4
30
Zhengzhou
2024-12-04
By invitation
The First Affiliated Hospital of Zhengzhou University
Phase 2
50
Zhengzhou
2024-11-08
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 1/2
29
Zhengzhou
2024-10-10
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
300
Zhengzhou
2024-09-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
208
Zhengzhou
2024-08-15
Not yet open
The First Affiliated Hospital of Zhengzhou University
Phase 2
20
Zhengzhou
2024-07-06
Recruiting
The First Affiliated Hospital of Zhengzhou University
Not applicable
20
Zhengzhou
2024-03-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
112
Zhengzhou
2023-03-08
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
188
Zhengzhou
2023-03-02
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
60
Zhengzhou
2022-06-20
Recruiting
The First Affiliated Hospital of Zhengzhou University
Phase 2
130
Zhengzhou
2022-01-15
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
3,500
Zhengzhou
2017-01-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
2,500
Zhengzhou
2017-01-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
3,000
Zhengzhou
2017-01-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
3,000
Zhengzhou
2017-01-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
10,000
Zhengzhou
2010-01-01
Recruiting
The First Affiliated Hospital of Zhengzhou University
Observational
10,000
Zhengzhou
2010-01-01
Recruiting
Azoospermia Patients
NCT03991663Healthy Related
The First Affiliated Hospital of Zhengzhou University
Observational
10,000
Zhengzhou
2010-01-01
Recruiting
Primary Ovarian Insufficient Patients
NCT03989154Healthy Related
The First Affiliated Hospital of Zhengzhou University
Observational
10,000
Zhengzhou
2010-01-01
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/zhengzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Zhengzhou that also match the filters currently applied.

How many clinical trials are recruiting in Zhengzhou?

25 of the 38 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 11 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhengzhou), 38 studies
PhaseStudiesRecruitingShare
Phase 2171244.7%
Observational12931.6%
Phase 3307.9%
Not applicable215.3%
Phase 1/2215.3%
Phase 1112.6%
Phase 4112.6%

Most active sponsors

Lead sponsors with the most studies (Zhengzhou)
Lead sponsorStudiesRecruiting
The First Affiliated Hospital of Zhengzhou University3825
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.